Llwytho...
PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
According to recent guidelines, oral dabigatran etexilate is indicated for stroke and systemic embolism prevention in patients with atrial fibrillation (AF). Aim. Based on the RE-LY study to evaluate the cost-effectiveness of dabigatran etexilate versus warfarin prescribed in “real-world” settings f...
Wedi'i Gadw mewn:
Prif Awduron: | , , , |
---|---|
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
Stolichnaya Izdatelskaya Kompaniya
2015-12-01
|
Cyfres: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Pynciau: | |
Mynediad Ar-lein: | https://www.rpcardio.com/jour/article/view/397 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|